Article

Online Follow-up Visits Provide Similar Clinical Outcomes as Office Visits

According to the results of a study conducted by Massachusetts General Hospital, patients with acne who complete a follow-up visit via a secure website may achieve similar clinical outcomes as patients who receive in-person visits.

Patients with acne who complete a follow-up visit via a secure website may achieve similar clinical outcomes as patients who receive in-person visits, according to the results of a new study from Massachusetts General Hospital that was led by Alice J. Watson, MBChB, MRCP, MPH and Hagit Bergman, MD, MPH.

Watson, Bergman, and their research team asked a total of 151 patients with mild to moderate facial acne to carry out four follow-up visits, either by an e-visit platform or conventional office care. Every six weeks, the patients using the e-visit platform were asked to send images of their skin and an update, through the secure website, to the dermatologist. The primary outcome the researchers looked at was the change in total inflammatory lesion count between the first and last visit.

Among the initial 151 patients who began the study, 121 completed it. The decrease in total inflammatory lesion count was similar in both groups of patients, 6.67 and 9.39, respectively (P = .49), according to an abstract of the study published in Archives of Dermatology.

In addition to the medical outcomes, the researchers also evaluated other parameters. Participants and physicians were both satisfied with comparable care, regardless of visit type (P = .06 and P = .16, respectively). Although e-visits were time saving for patients, they were time-neutral for dermatologists – 4 minutes, 8 seconds versus 4 minutes, 42 seconds (P = .57).

“Delivering follow-up care to acne patients via an e-visit platform produced clinical outcomes equivalent to those of conventional office visits,” the researchers conclude in the Archives of Dermatology abstract.

Related Videos
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.